DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)
DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)